[go: up one dir, main page]

EP1613214A2 - Respiratory monitoring, diagnostic and therapeutic system - Google Patents

Respiratory monitoring, diagnostic and therapeutic system

Info

Publication number
EP1613214A2
EP1613214A2 EP04750135A EP04750135A EP1613214A2 EP 1613214 A2 EP1613214 A2 EP 1613214A2 EP 04750135 A EP04750135 A EP 04750135A EP 04750135 A EP04750135 A EP 04750135A EP 1613214 A2 EP1613214 A2 EP 1613214A2
Authority
EP
European Patent Office
Prior art keywords
sensor
recited
breath
receiver
chemical parameter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP04750135A
Other languages
German (de)
French (fr)
Other versions
EP1613214A4 (en
EP1613214B1 (en
Inventor
Ross Tsukashima
Jeffery Schipper
Leo Roucher
Erich Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seirra Medical Technology Inc
Original Assignee
Seirra Medical Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seirra Medical Technology Inc filed Critical Seirra Medical Technology Inc
Publication of EP1613214A2 publication Critical patent/EP1613214A2/en
Publication of EP1613214A4 publication Critical patent/EP1613214A4/en
Application granted granted Critical
Publication of EP1613214B1 publication Critical patent/EP1613214B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14539Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Measuring devices for evaluating the respiratory organs
    • A61B5/083Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0003Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0057Pumps therefor
    • A61M16/0066Blowers or centrifugal pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/06Respiratory or anaesthetic masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/14Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3569Range sublocal, e.g. between console and disposable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • A61M2230/43Composition of exhalation

Definitions

  • the field of art to which this invention relates is in the monitoring of certain parameters and transfer of such information to facilitate therapeutic treatment for patients suffering from respiratory diseases, such as asthma. More specifically, the present invention monitors r the pH level of a patient' s breath and provides data for determining the frequency and volume of a therapeutic dose to be administered to the asthmatics' airways.
  • Asthma is characterized by symptoms of wheezing, coughing, chest tightness, and shortness of breath. Manifestations include constriction (the tightening of the muscles around the airways) and inflammation (the swelling and irritation of the airways) that can be triggered through exposure to smoking, dust mites, pets, activity, cold, infection, weather, pollen, etc.
  • COPD chronic obstructive pulmonary disease
  • GSD gastro-esophageal reflux disease
  • GERD can also manifest in the micro-aspiration of acid from the esophagus and into the lungs, damaging tissue, and causing swelling and irritation of the vagus nerve. This irritation of the vagus nerve, which is common to both the esophagus and the bronchial tree, causes constriction of the airways. Acid refluxes past the lower esophageal sphincter and causes anatomical damage, sleep disordered breathing, and dietary affects. it has also been found that bronchial dilators can relax the lower esophageal sphincter and trigger GERD induced asthmatic conditions. Sleep apnea has also been found to trigger reflux events.
  • the present invention pertains to an invention for monitoring the pH level of a patient' s breath in a typical mask and provides a means for transferring this data to a processing receiver for diagnosing and determining the frequency and volume of a therapeutic dose to be administered to a patient with a respiratory condition such as asthma.
  • Monitoring of a patients' breath chemistry is provided by a system that includes a miniaturized pH sensor, provides for real-time monitoring of patient airway pH values, and utilizes solid state cooling to precipitate moisture from a patient' s breath .
  • a general respiratory mask is mounted with a miniaturized pH sensor and data transfer means e.g. direct wiring or by providing a transmitter with an antenna for wireless transferring of the pH data to a processing receiver.
  • the temperature of the pH sensor is lowered below the dew point of the exhaled patient breath by a solid-state Peltier junction engaged on one side to a heat sink.
  • a thermocouple is provided to monitor the temperature of the sensor for more accurate pH calculations . Keeping the sensor temperature below the dew point will cause the patient' s exhaled breath to condense as a liquid in close proximity to the surface of the sensor. It is commonly known that monitoring of pH is significantly more accurate if measuring a condensed liquid.
  • a transmitter with an antenna transfers the
  • the pH data is transferred or updated at specific intervals, which can be varied according to the patient's needs, to the processing receiver that is engaged to the treatment and humidifier apparatuses.
  • the processing receiver computes , and diagnoses the chemistry data and determines what apparatus and at what frequency it should be activated.
  • the present invention mask is also fitted with a means to remove the condensed liquid through an exhaust port or the connected pneumatic hose to remove unnecessary and accumulated breath condensate.
  • Figure 1 is a perspective representation of the present invention systems , showing the various components of the system, including a mask apparatus fitted with a heat sink and pH sensing means, a continuous positive airway pressure (CPAP) device connected to the mask
  • CPAP continuous positive airway pressure
  • a processing receiver electrically connected to the mask apparatus, and a nebulizer/atomizer/humidifier device electrically connected to the processing receiver.
  • Figure 2 is a sectional side view of the general mask apparatus demonstrating in more detail of the orientation and components of the mask, and pH sensing means.
  • Figure 3 is a sectional view taken from Figure 1 demonstrating the general location of the pH sensor, cooling shank, thermocouple and fluid pool on the sampling plate for condensing and containing a patient' s breath .
  • Figure 4 is a sectional side view taken from Figure 2 demonstrating in more detail the relative locations of the heat sink, Peltier junction, body and head of cooling transfer shank, thermocouple, and pH sensor.
  • Figure 5 is a schematic representation of the treatment nebulizer/atomizer/ humidifier device, demonstrating a base unit having an on/off switch, operating lights, a medicament storage container, and interconnection for attaching the pneumatic hose.
  • Figure 6 is an electrical schematic of the general components in the processing receiver.
  • FIGS 7 and 8 are flowcharts showing the sequential computational steps employed by the processing receiver. DESCRIPTION OF THE PREFERRED EMBODIEMENTS
  • the present invention provides a system and method for monitoring physiological parameters from a patient' s exhaled breath and communicates this information to a processing computer/receiver that diagnoses the information.
  • the system can use computational instructions to activate and de-activate an electrically connected treatment nebulizer/ atomizer/humidifier device, and can be integrated with a continuous positive airway pressure (CPAP) device.
  • CPAP continuous positive airway pressure
  • Figure 1 illustrates that the present invention is a system 10 comprised of several components.
  • a typical mask apparatus 36 is fitted with a securing strap or typical headgear apparatus 38.
  • the typical mask apparatus 36 is generally fabricated from a polymeric and/or silicone material and configured to fit over a patient's nose, or nose and mouth, to assist in breathing conditions .
  • the securing strap 38 is made from a flexible material and is positioned around the patient' s head such that the mask substantially engages the patient' s face and mouth area, minimizing ambient air from entering the boundaries of the mask. It is contemplated by the Applicants that other mask configurations and types can be employed with the present invention to achieve the goal of monitoring, diagnosing and treating respiratory conditions in patients .
  • a heat sink 34 Shown attached to the front of the typical mask apparatus 36 is a heat sink 34 with made generally from a material that has good heat conduction properties, such as certain metallic elements and alloys . Some candidates for the heat sink 34 and fins 35 are aluminum, copper, silver and gold.
  • the heat sink 34 is fitted with fins 35 to increase the surface area of the heat sink 34 to dispense heat generated by the system.
  • the heat sink 34 is shown 10 secured to the mask by screws 37 but can also be attached with other commonly known methods, such as adhesives.
  • the typical mask apparatus 36 is connected to the exit i port 22 of a CPAP device 16 by means of a pneumatic hose 18.
  • the hose can be manufactured from a variety of materials, including polymers such as polyethylene, ctiloride or
  • Electrical wire 29 is typical in that the internal core comprises an electrical conductive metallic material and is encased by a nonconductive jacket.
  • Processing receiver 26 is connected to the CPAP device 16 by an electrical wire 24 for controlling the activation of air generated by the CPAP device 16 and transferred to the typical mask apparatus 36. Also, an electrical connection by means of a wire 31 to the processing receiver 26 is a
  • a wireless means 40 can be utilized instead to communicate between the processing receiver 26 with an antenna 28 to the treatment nebulizer/atomizer/ ⁇ _- humidifier device 32.
  • a wireless means also can be employed to communicate between the typical mask apparatus 36 and the processing receiver 26.
  • a wireless means also can be employed to communicate between the processing
  • wireless means for communicating between various components can be accomplished using radio frequency waves, microwaves , ultrasonic waves , or light
  • the treatment nebulizer/atomizer/humidifier device 32 is pneumatically connected to hose 18 at some point along 30 its length between the CPAP device 16 and the typical mask apparatus 36.
  • the treatment nebulizer/atomizer/humidifier device 32 has a medicament storage chamber 33 where various types of therapeutic medicaments can be delivered to the
  • Figure 2 illustrates a sectional side view of the general mask apparatus demonstrating in more detail the orientation and components of the mask 36, the heat sink 34 and the pH sensing means 46.
  • the mask When deployed, the mask forms a sampling chamber 39 between the mask 36 and the patient' s facial area that is in pneumatic connection with the patient's respiratory system.
  • This sampling chamber 39 contains a current sample of the patient' s breath that enters, through a one-way valve 42 , and into the condensing chamber 41 formed between the exterior mask surface and the back surface of the heat sink apparatus .
  • the heat sink is mounted to the mask apparatus 36 by screws 37 or alternatively using adhesive or other mounting technology.
  • FIG 3 is a sectional view taken from Figure 1 demonstrating the general location of the pH sensor, cooling shank, thermocouple and fluid pool on the sampling plate for condensing and containing a patient's breath.
  • T e sampling plate 43 functions to condense the patient' s breath and form a pool of liquefied breath such that the sensor is immersed in liquid and monitors the pH level .
  • the sampling plate 43 is generally manufactured from a material that has good heat conduction properties , such as certain metallic elements and alloys . Some candidates are aluminum, copper, silver and gold.
  • Figure 3 shows the general location of the pH sensor 46, cooling shank head
  • thermocouple 52 thermocouple 52 and fluid pool area 58 for containing
  • the pH sensor 46 is comprised from a metallic antimony or similar alloy that is fitted with a plurality of wires or wireless means to communicate the analog pH information monitored by the sensor to a processing receiver 26.
  • the thermocouple is fabricated from standard metallic components and is fitted with a plurality of wires or wireless means to communicate the analog temperature information monitored by the thermocouple to the processing receiver 26.
  • the cooling shank head 56 is part of a cooling shank that penetrates the sampling plate 43 and ultimately engages the Peltier junction 50 (see Fig. 4) .
  • the cooling head 56 and body shank 54 (see Fig. 4) is fabricated generally from a material that has good heat conduction properties, such as certain metallic elements and alloys. Some candidates are aluminum, copper, silver and gold.
  • the cooling head 56 is engaged to and reduces the temperature of the sampling plate 43 and pooling area 58 to facilitate the condensation of breath into a liquid that pools in the pooling area 58 that covers and becomes exposed to the pH sensor 46.
  • both the thermocouple 52 and the pH sensor 46 are mounted within a lumen formed within the cooling shank head 56.
  • the thermocouple 52 is shown residing within the cooling shank head 56.
  • the pH sensor extends beyond the cooling head 56 and into the pooling area 58.
  • the sensor 46 can be mounted such that the head of the sensor enters the pooling area from the bottom and extends back
  • sampling plate 43 12 through the back side of the sampling plate 43, as shown in Figure 4. If appropriate, holes 45 in sampling plate 43 can be threaded to receive screws 37.
  • the pooling area 58 shown in Figure 3 portrays a dumbbell shape. It is contemplated by the Applicant that various other shapes, side curvatures and dimensions may be employed to facilitate capturing the condensed breath and forming a pool of liquid that immerses the head of the pH sensor 46.
  • FIG 4 illustrates a sectional side view taken from Figure 1 demonstrating in more detail the relative locations of the heat sink 34, the solid-state Peltier junction 50, body 54 and head 56 of cooling transfer shank, thermocouple 52, and pH sensor 46.
  • the Peltier junction 50 engages the backside of heat sink .34.
  • the Peltier junction 50 is connected by wires 51 to a DC power source, such as a battery (not shown) that generally is in the range of 0.5 to 12 volts .
  • the Peltier junction functions as a heat pump, removing heat from the cooling body shank 54 and head 56, thereby reducing its relative temperature, and transferring the heat to the heat sink 34 and fins 35 that dissipates it into the environment.
  • the Peltier junction reduces the temperature of the cooling head and associated components, the adjoining pooling area 58 and sampling plate 43 temperatures are also reduced. The net effect of this operation is that the these metallic surfaces have a temperature lower than the dew point, which causes the
  • wires 48 and 49 Electronic communication from the pH sensor wires 48 and the thermocouple wires 49 that are further connected to a wire or wireless means for communication to the processing receiver 26.
  • wires 48 and 49 would terminate in an antenna (not shown) and communicate with an antenna associated with the processing receiver 26.
  • non-liquid pH sensing means by which a direct pH measurement of non-condensed breath may be utilized, is contemplated by the Applicants.
  • Figure 5 is a schematic representation of the treatment nebulizer/atomizer/ humidifier device 32 , demonstrating a base unit having a on/off switch 102 , operating lights 104, a medicament chamber 33, and interconnection 108 for attaching to the pneumatic hose 18.
  • the treatment nebulizer/atomizer/ humidifier device 32 has an outer shell surrounding various mechanical and electrical components that function to deliver the therapeutic dose.
  • the shell can be made of a variety of materials, including plastics such as polyethylene, polystyrene, ABS, nylon, delrin, or polyethylene terephthalate (PET) .
  • PET polyethylene terephthalate
  • the treatment nebulizer/atomizer /humidifier device 32 communicates with the processing receiver by direct wiring (not shown) or by use of wireless means employing an antenna means 110.
  • Operating light 104 can consist of LED, LCD, fluorescent, or halide or other means to communicate such conditions, as on/off, medicament chamber emp y, etc. Also, the Applicant contemplates a plurality of operating lights can be employed having different functions .
  • This device can be modified or fabricated so that 1) it can be remotely activated by the processing receiver 26, and 2) adapted to connect to the pneumatic tube by an appropriate connection
  • the medicament chamber 33 can contain liquid, gaseous or powdered therapeutics that the treatment nebulizer/
  • atomizer/humidifier device 32 is designed to administer to the pneumatic system upon instructions from the processing receiver 26. It is contemplated that the medicament chamber 33 could include a plurality of medicaments in
  • treatment nebulizer/atomizer/ humidifier device 32 can select to administer one or more, or in a combination, multiple medicaments stored in the medicament chamber 33.
  • Figure 6 is a simplified electrical schematic of the general components in the processing receiver 26.
  • the microprocessor 70 that processes the information supplied by the thermocouple and sensor and use internal instructions to control other devices .
  • the microprocessor has an EEPROM memory section that allows for specific programming to be incorporated as processing instructions.
  • the microprocessor must have the capability to convert analog signals into digital information for decoding and processing.
  • An example of a microprocessor that could be used in the processing receiver 26 is the PIC16F876 28-pin 8-Bin CMOS FLASH microcontrollers manufactured by Microchip Technology, Inc.
  • This particular microprocessor has a 128K EEPROM Data memory bank for flash memory of specific instructions and utilizes a 35-word instruction set. It also has five 10- bit Analog-to-Digital Inputs that are necessary for converting the information obtained from the pH sensor 46 and thermocouple 52 from its analog format into a digitized form for processing by the instruction sets of the microprocessor 70.
  • the microprocessor 70 includes a timing crystal 72 used for clocking operations and is connected to and energized by an approximate 12 volt power supply 69. Also included in the circuit is a power transistor 66 with an electrical connection to the 12-volt power supply, a 5-volt regulator 68, and a ground 78.
  • thermocouple analog data that is communicated either through direct wiring or through a wireless means that is amplified by circuit 76 and connected to the microprocessor 70 through another one of the analog-to-digital modules .
  • the transmitted data can be recorded, compressed and stored as it is received using a memory chip set or memory circuit within the microprocessor (not shown) . Subsequently, the data stored can be downloaded into an external data retrieval device, which can be a computer or other analysis machine.
  • Figured 7 and 8 illustrate flowcharts showing the sequential computational steps employed by the processing receiver 26.
  • the microprocessor 70 has an EEPROM memory section that allows for specific programming to be incorporated as processing instructions .
  • the steps programmed in the microprocessor 70 are outlined in the flowcharts, starting with the 1) monitoring of breath chemistry 120 without CPAP support ( Figure 7) 2) the monitoring of breath chemistry and breathing rates (122) when CPAP supported ( Figure 8) .
  • the analog information obtained from the sensor and the thermocouple is converted
  • thermocouple data to calculate an accurate pH level that is stored in a registry.
  • this data can be diagnosed by the microprocessor 140 and stored in a memory bank whereby the microprocessor can create diagnostic reports 150.
  • the stored data is then compared to a threshold value or range 160 programmed in the instruction set of the microprocessor 70. For example, if the pH level does not reach the threshold value, then no actions are performed and the instruction set loops back to read breath chemistry ( Figure 7) or breath chemistry and monitor breathing rates ( Figure 8) . If the pH level reaches the threshold value, then the microprocessor 70 determines the appropriate therapy 170.
  • the present invention will: 1) Monitor; 2) Diagnose; 3) Treat a respiratory disease, with and without CPAP therapy.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Optics & Photonics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Disclosed is a system and method for monitoring diagnosing, and treating certain respiratory conditions, such as asthma. The system includes a mask apparatus fitted with a pH sensor and thermocouple, a continuous positive airway pressure (CPAP) device, a processing receiver, and a therapeutic nebulizer/atomizer/humidifier device. The mask apparatus, CPAP device and therapeutic nebulizer/atomizer/humidifier device are connected by a pneumatic means. The pH sensor and the thermocouple are in electrical communication with the processing receiver that controls, through an electronic means, the CPAP device and therapeutic nebulizer/atomizer/humidifier device. The electrical communications can be in the form of a plurality of wires or employ wireless means.

Description

Respiratory Monitoring, Diagnostic and Therapeutic System
FIELD OF THE INVENTION
The field of art to which this invention relates is in the monitoring of certain parameters and transfer of such information to facilitate therapeutic treatment for patients suffering from respiratory diseases, such as asthma. More specifically, the present invention monitors r the pH level of a patient' s breath and provides data for determining the frequency and volume of a therapeutic dose to be administered to the asthmatics' airways.
BACKGROUND OF THE INVENTION
Recently, it has been reported that the monitoring of acidity or pH of a patient' s breath could help physicians in estimating the degree of air passage inflammation in the lungs, now considered a key contributor to asthma and other respiratory conditions . Asthma is characterized by symptoms of wheezing, coughing, chest tightness, and shortness of breath. Manifestations include constriction (the tightening of the muscles around the airways) and inflammation (the swelling and irritation of the airways) that can be triggered through exposure to smoking, dust mites, pets, activity, cold, infection, weather, pollen, etc.
A clinical study of people with chronic obstructive pulmonary disease (COPD) , bronchiectasis and asthma demonstrated more acidic levels in COPD and bronchiectasis patients, which is indicative of the chronic inflammation
2 tha these patients experience. This study also observed an increase acidic level measured from the breath of patients suffering from moderate asthma when compared to mild forms of the disease. It was also found that the asthmatics' breath was much more acidic during asthma attacks, but normalized after anti-inflammatory medication was administered.
This data suggests that the monitoring of an asthmatics' breath for pH might be an effective way to measure the degree of inflammation in the air passages . Furthermore, this data suggests that close monitoring of an asthmatic' s breath pH could lead to prompt and effective treatment, minimizing the occurrence of asthma attacks and provide overall better management.
It is estimated that 18-26 million people in the United Stated su fer from asthmatic conditions . It is also believed that over 5.6 million of these asthma suffers are under the age of 18, ranking this disease as the 8th worst chronic condition.
Studies have also shown that gastro-esophageal reflux disease (GERD) induced asthma affects approximately 40% of the US Adult Population and that 60-80 percent of all asthma patients have GERD. Gastro-esophageal reflux is a condition in which gastric acid refluxes from the stomach and into the esophagus. Frequent reflux episodes may result in a potentially severe problem known as gastro- esophageal reflux disease. GERD is the most common cause
3 of dyspepsia or heartburn. GERD can also manifest in the micro-aspiration of acid from the esophagus and into the lungs, damaging tissue, and causing swelling and irritation of the vagus nerve. This irritation of the vagus nerve, which is common to both the esophagus and the bronchial tree, causes constriction of the airways. Acid refluxes past the lower esophageal sphincter and causes anatomical damage, sleep disordered breathing, and dietary affects. it has also been found that bronchial dilators can relax the lower esophageal sphincter and trigger GERD induced asthmatic conditions. Sleep apnea has also been found to trigger reflux events.
Current pH monitoring suffers from the following drawbacks, 1) invasive procedure, 2) not well tolerated by some patients, 3) catheter or capsule placement must be performed by a physician, 4) capsule cannot be placed above the Upper Esophageal Sphincter (UES) and 5) there are no defined standards (DeMeester Score) for UES evaluation.
Accordingly, there is a need in this art for a novel, pH monitoring mask with electronic or wireless communication linked to a processing receiver that activates a therapeutic nebulizer/atomizer/humidifier for treating asthmatic or other respiratory conditions .
SUMMARY OF THE INVENTION
The present invention pertains to an invention for monitoring the pH level of a patient' s breath in a typical mask and provides a means for transferring this data to a processing receiver for diagnosing and determining the frequency and volume of a therapeutic dose to be administered to a patient with a respiratory condition such as asthma. Monitoring of a patients' breath chemistry is provided by a system that includes a miniaturized pH sensor, provides for real-time monitoring of patient airway pH values, and utilizes solid state cooling to precipitate moisture from a patient' s breath .
A general respiratory mask is mounted with a miniaturized pH sensor and data transfer means e.g. direct wiring or by providing a transmitter with an antenna for wireless transferring of the pH data to a processing receiver. The temperature of the pH sensor is lowered below the dew point of the exhaled patient breath by a solid-state Peltier junction engaged on one side to a heat sink. A thermocouple is provided to monitor the temperature of the sensor for more accurate pH calculations . Keeping the sensor temperature below the dew point will cause the patient' s exhaled breath to condense as a liquid in close proximity to the surface of the sensor. It is commonly known that monitoring of pH is significantly more accurate if measuring a condensed liquid. A transmitter with an antenna transfers the
5 observed pH data by employing one of many wireless methods, such as radio-frequency (RF) energy. Alternately, the transfer of observed pH data is accomplished by direct wire methods .
The pH data is transferred or updated at specific intervals, which can be varied according to the patient's needs, to the processing receiver that is engaged to the treatment and humidifier apparatuses. The processing receiver computes, and diagnoses the chemistry data and determines what apparatus and at what frequency it should be activated.
The present invention mask is also fitted with a means to remove the condensed liquid through an exhaust port or the connected pneumatic hose to remove unnecessary and accumulated breath condensate.
These and other features, aspects and advantages of the present invention will become better understood with reference to the following descriptions and claims .
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a perspective representation of the present invention systems , showing the various components of the system, including a mask apparatus fitted with a heat sink and pH sensing means, a continuous positive airway pressure (CPAP) device connected to the mask
6 apparatus, a processing receiver electrically connected to the mask apparatus, and a nebulizer/atomizer/humidifier device electrically connected to the processing receiver.
Figure 2 is a sectional side view of the general mask apparatus demonstrating in more detail of the orientation and components of the mask, and pH sensing means.
Figure 3 is a sectional view taken from Figure 1 demonstrating the general location of the pH sensor, cooling shank, thermocouple and fluid pool on the sampling plate for condensing and containing a patient' s breath .
Figure 4 is a sectional side view taken from Figure 2 demonstrating in more detail the relative locations of the heat sink, Peltier junction, body and head of cooling transfer shank, thermocouple, and pH sensor.
Figure 5 is a schematic representation of the treatment nebulizer/atomizer/ humidifier device, demonstrating a base unit having an on/off switch, operating lights, a medicament storage container, and interconnection for attaching the pneumatic hose.
Figure 6 is an electrical schematic of the general components in the processing receiver.
Figures 7 and 8 are flowcharts showing the sequential computational steps employed by the processing receiver. DESCRIPTION OF THE PREFERRED EMBODIEMENTS
The present invention provides a system and method for monitoring physiological parameters from a patient' s exhaled breath and communicates this information to a processing computer/receiver that diagnoses the information. The system can use computational instructions to activate and de-activate an electrically connected treatment nebulizer/ atomizer/humidifier device, and can be integrated with a continuous positive airway pressure (CPAP) device.
Figure 1 illustrates that the present invention is a system 10 comprised of several components. As shown in the Figure, a typical mask apparatus 36 is fitted with a securing strap or typical headgear apparatus 38. The typical mask apparatus 36 is generally fabricated from a polymeric and/or silicone material and configured to fit over a patient's nose, or nose and mouth, to assist in breathing conditions . The securing strap 38 is made from a flexible material and is positioned around the patient' s head such that the mask substantially engages the patient' s face and mouth area, minimizing ambient air from entering the boundaries of the mask. It is contemplated by the Applicants that other mask configurations and types can be employed with the present invention to achieve the goal of monitoring, diagnosing and treating respiratory conditions in patients . Shown attached to the front of the typical mask apparatus 36 is a heat sink 34 with made generally from a material that has good heat conduction properties, such as certain metallic elements and alloys . Some candidates for the heat sink 34 and fins 35 are aluminum, copper, silver and gold. The heat sink 34 is fitted with fins 35 to increase the surface area of the heat sink 34 to dispense heat generated by the system. The heat sink 34 is shown 10 secured to the mask by screws 37 but can also be attached with other commonly known methods, such as adhesives.
The typical mask apparatus 36 is connected to the exit i port 22 of a CPAP device 16 by means of a pneumatic hose 18. The hose can be manufactured from a variety of materials, including polymers such as polyethylene, ctiloride or
Electrical wire 29 is typical in that the internal core comprises an electrical conductive metallic material and is encased by a nonconductive jacket. Processing receiver 26 is connected to the CPAP device 16 by an electrical wire 24 for controlling the activation of air generated by the CPAP device 16 and transferred to the typical mask apparatus 36. Also, an electrical connection by means of a wire 31 to the processing receiver 26 is a
10 treatment nebulizer/atomizer/ humidifier device 32. As an alternate method, a wireless means 40 can be utilized instead to communicate between the processing receiver 26 with an antenna 28 to the treatment nebulizer/atomizer/ ι _- humidifier device 32. Although not shown in detail in Figure 1, a wireless means also can be employed to communicate between the typical mask apparatus 36 and the processing receiver 26. In addition, a wireless means also can be employed to communicate between the processing
20 receiver 26 and the CPAP device 16. As appreciated by those skilled in the art, wireless means for communicating between various components can be accomplished using radio frequency waves, microwaves , ultrasonic waves , or light
25 optics .
The treatment nebulizer/atomizer/humidifier device 32 is pneumatically connected to hose 18 at some point along 30 its length between the CPAP device 16 and the typical mask apparatus 36. The treatment nebulizer/atomizer/humidifier device 32 has a medicament storage chamber 33 where various types of therapeutic medicaments can be delivered to the
35 pneumatic system and to the patient at intervals commanded by the processing receiver 26.
Figure 2 illustrates a sectional side view of the general mask apparatus demonstrating in more detail the orientation and components of the mask 36, the heat sink 34 and the pH sensing means 46. When deployed, the mask forms a sampling chamber 39 between the mask 36 and the patient' s facial area that is in pneumatic connection with the patient's respiratory system. This sampling chamber 39 contains a current sample of the patient' s breath that enters, through a one-way valve 42 , and into the condensing chamber 41 formed between the exterior mask surface and the back surface of the heat sink apparatus . The heat sink is mounted to the mask apparatus 36 by screws 37 or alternatively using adhesive or other mounting technology.
Figure 3 is a sectional view taken from Figure 1 demonstrating the general location of the pH sensor, cooling shank, thermocouple and fluid pool on the sampling plate for condensing and containing a patient's breath. T e sampling plate 43 functions to condense the patient' s breath and form a pool of liquefied breath such that the sensor is immersed in liquid and monitors the pH level . The sampling plate 43 is generally manufactured from a material that has good heat conduction properties , such as certain metallic elements and alloys . Some candidates are aluminum, copper, silver and gold. Figure 3 shows the general location of the pH sensor 46, cooling shank head
56, thermocouple 52 and fluid pool area 58 for containing
11 condensed breath. The pH sensor 46 is comprised from a metallic antimony or similar alloy that is fitted with a plurality of wires or wireless means to communicate the analog pH information monitored by the sensor to a processing receiver 26. Similarly, the thermocouple is fabricated from standard metallic components and is fitted with a plurality of wires or wireless means to communicate the analog temperature information monitored by the thermocouple to the processing receiver 26. The cooling shank head 56 is part of a cooling shank that penetrates the sampling plate 43 and ultimately engages the Peltier junction 50 (see Fig. 4) . The cooling head 56 and body shank 54 (see Fig. 4) is fabricated generally from a material that has good heat conduction properties, such as certain metallic elements and alloys. Some candidates are aluminum, copper, silver and gold. The cooling head 56 is engaged to and reduces the temperature of the sampling plate 43 and pooling area 58 to facilitate the condensation of breath into a liquid that pools in the pooling area 58 that covers and becomes exposed to the pH sensor 46. Shown here, both the thermocouple 52 and the pH sensor 46 are mounted within a lumen formed within the cooling shank head 56. The thermocouple 52 is shown residing within the cooling shank head 56. The pH sensor extends beyond the cooling head 56 and into the pooling area 58. The Applicant contemplates that other mounting positions for the thermocouple 52 and pH sensor 46 can be employed without sacrificing any performance. For example, the sensor 46 can be mounted such that the head of the sensor enters the pooling area from the bottom and extends back
12 through the back side of the sampling plate 43, as shown in Figure 4. If appropriate, holes 45 in sampling plate 43 can be threaded to receive screws 37.
Within the collection region 47, the pooling area 58 shown in Figure 3 portrays a dumbbell shape. It is contemplated by the Applicant that various other shapes, side curvatures and dimensions may be employed to facilitate capturing the condensed breath and forming a pool of liquid that immerses the head of the pH sensor 46.
Figure 4 illustrates a sectional side view taken from Figure 1 demonstrating in more detail the relative locations of the heat sink 34, the solid-state Peltier junction 50, body 54 and head 56 of cooling transfer shank, thermocouple 52, and pH sensor 46. As shown in this figure, the Peltier junction 50 engages the backside of heat sink .34. The Peltier junction 50 is connected by wires 51 to a DC power source, such as a battery (not shown) that generally is in the range of 0.5 to 12 volts .
The Peltier junction functions as a heat pump, removing heat from the cooling body shank 54 and head 56, thereby reducing its relative temperature, and transferring the heat to the heat sink 34 and fins 35 that dissipates it into the environment. As the Peltier junction reduces the temperature of the cooling head and associated components, the adjoining pooling area 58 and sampling plate 43 temperatures are also reduced. The net effect of this operation is that the these metallic surfaces have a temperature lower than the dew point, which causes the
13 sampled breath to condense and form a pool of liquefied breath in the pooling area 58.
Electronic communication from the pH sensor wires 48 and the thermocouple wires 49 that are further connected to a wire or wireless means for communication to the processing receiver 26. In the case of a wireless means, wires 48 and 49 would terminate in an antenna (not shown) and communicate with an antenna associated with the processing receiver 26.
Alternatively, a non-liquid pH sensing means, by which a direct pH measurement of non-condensed breath may be utilized, is contemplated by the Applicants.
Figure 5 is a schematic representation of the treatment nebulizer/atomizer/ humidifier device 32 , demonstrating a base unit having a on/off switch 102 , operating lights 104, a medicament chamber 33, and interconnection 108 for attaching to the pneumatic hose 18.
The treatment nebulizer/atomizer/ humidifier device 32 has an outer shell surrounding various mechanical and electrical components that function to deliver the therapeutic dose. The shell can be made of a variety of materials, including plastics such as polyethylene, polystyrene, ABS, nylon, delrin, or polyethylene terephthalate (PET) . The treatment nebulizer/atomizer /humidifier device 32 communicates with the processing receiver by direct wiring (not shown) or by use of wireless means employing an antenna means 110. The base unit and
14 various components of the treatment nebulizer/ atomizer/humidifier can be fabricated from polymeric or metallic materials . Operating light 104 can consist of LED, LCD, fluorescent, or halide or other means to communicate such conditions, as on/off, medicament chamber emp y, etc. Also, the Applicant contemplates a plurality of operating lights can be employed having different functions . The art associated with atomization of
10 particles and humidification processes are known in the art. Many commercially available units can satisfy the basic requirements for the treatment nebulizer/atomizer/ humidifier device 32. One such device is the MicroAir ι_- portable ultrasonic nebulizer manufactured by Omron
Healthcare, Inc. of Vernon Hills, Illinois. This device can be modified or fabricated so that 1) it can be remotely activated by the processing receiver 26, and 2) adapted to connect to the pneumatic tube by an appropriate connection
20 108 as shown in Figure 5.
The medicament chamber 33 can contain liquid, gaseous or powdered therapeutics that the treatment nebulizer/
25 atomizer/humidifier device 32 is designed to administer to the pneumatic system upon instructions from the processing receiver 26. It is contemplated that the medicament chamber 33 could include a plurality of medicaments in
30 various compartments in the medicament chamber 33. It is also contemplated that treatment nebulizer/atomizer/ humidifier device 32 can select to administer one or more, or in a combination, multiple medicaments stored in the medicament chamber 33.
35
15 Figure 6 is a simplified electrical schematic of the general components in the processing receiver 26. In the center is the microprocessor 70 that processes the information supplied by the thermocouple and sensor and use internal instructions to control other devices . The microprocessor has an EEPROM memory section that allows for specific programming to be incorporated as processing instructions. Furthermore, the microprocessor must have the capability to convert analog signals into digital information for decoding and processing. An example of a microprocessor that could be used in the processing receiver 26 is the PIC16F876 28-pin 8-Bin CMOS FLASH microcontrollers manufactured by Microchip Technology, Inc. This particular microprocessor has a 128K EEPROM Data memory bank for flash memory of specific instructions and utilizes a 35-word instruction set. It also has five 10- bit Analog-to-Digital Inputs that are necessary for converting the information obtained from the pH sensor 46 and thermocouple 52 from its analog format into a digitized form for processing by the instruction sets of the microprocessor 70.
The microprocessor 70 includes a timing crystal 72 used for clocking operations and is connected to and energized by an approximate 12 volt power supply 69. Also included in the circuit is a power transistor 66 with an electrical connection to the 12-volt power supply, a 5-volt regulator 68, and a ground 78.
16 The sensor analog data that is communicated either through direct wiring or through a wireless means that is then amplified by a circuit 74 and connected to the microprocessor 70 through one of the analog-to-digital modules .
In addition, the thermocouple analog data that is communicated either through direct wiring or through a wireless means that is amplified by circuit 76 and connected to the microprocessor 70 through another one of the analog-to-digital modules .
In certain embodiments, the transmitted data can be recorded, compressed and stored as it is received using a memory chip set or memory circuit within the microprocessor (not shown) . Subsequently, the data stored can be downloaded into an external data retrieval device, which can be a computer or other analysis machine.
Figured 7 and 8 illustrate flowcharts showing the sequential computational steps employed by the processing receiver 26. As described above, the microprocessor 70 has an EEPROM memory section that allows for specific programming to be incorporated as processing instructions . The steps programmed in the microprocessor 70 are outlined in the flowcharts, starting with the 1) monitoring of breath chemistry 120 without CPAP support (Figure 7) 2) the monitoring of breath chemistry and breathing rates (122) when CPAP supported (Figure 8) . The analog information obtained from the sensor and the thermocouple is converted
17 to digital information and transferred to the microprocessor. The microprocessor uses the thermocouple data to calculate an accurate pH level that is stored in a registry. Optionally, this data can be diagnosed by the microprocessor 140 and stored in a memory bank whereby the microprocessor can create diagnostic reports 150.
The stored data is then compared to a threshold value or range 160 programmed in the instruction set of the microprocessor 70. For example, if the pH level does not reach the threshold value, then no actions are performed and the instruction set loops back to read breath chemistry (Figure 7) or breath chemistry and monitor breathing rates (Figure 8) . If the pH level reaches the threshold value, then the microprocessor 70 determines the appropriate therapy 170.
These computational steps can be continued over and over again to detect, record, analyze and administer the appropriate therapeutic regime to manage patients with certain respiratory conditions .
The present invention will: 1) Monitor; 2) Diagnose; 3) Treat a respiratory disease, with and without CPAP therapy.
While the invention has been described in detail and with reference to specific embodiment thereof, it will be apparent to one skilled in the art that various changes and
18 modifications can be made therein without departing from the spirit and scope thereof.
19

Claims

CLAIMSWe Claim:
1. A system for monitoring a respiratory condition :
an apparatus for exposing a sensor to an individual' s breat ;
a processing receiver; and
said sensor in real-time communication with said receive .
2. The system as recited in claim 1 , wherein said apparatus is a general mask.
3. The system as recited in claim 1 , wherein said sensor is designed to monitor pH.
4. The system as recited in claim 1, wherein said respiratory condition is asthma.
5. The system as recited in claim 1, wherein said communication is accomplished by a plurality of wires
6. The system as recited in claim 1, wherein said communication is accomplished by a wireless means ,
20
7. The system as recited in claim 1 , wherein said apparatus includes a means to condense the individual's breath to form a liquid pool in close proximity to said sensor.
8. The system as recited in claim 7 , wherein said apparatus has a means to continuously circulate and replace said sample of liquefied breath with a fresh sample of liquefied condensed breath.
9. A system for monitoring and diagnosing a respiratory condition:
an apparatus for exposing a sensor to an individual's breath;
a processing receiver;
said sensor in real-time communication with said receiver; and
said processing receiver processing said information for determining various diagnoses .
10. The system as recited in claim 9, wherein said apparatus is a general mask.
11. The system as recited in claim 9, wherein said respiratory condition is asthma.
21
12. The system as recited in claim 9 , wherein said communication is accomplished by a plurality of wires .
13. The system as recited in claim 9, wherein said communication is accomplished by a wireless means.
14. The system as recited in claim 9 , wherein said sensor is designed to monitor pH.
15. The system as recited in claim 9, wherein said apparatus includes a means to condense the individual's breath to form a liquid pool in close proximity to said sensor.
16. The system as recited in claim 15, wherein said apparatus has a means to continuously circulate and replace said sample of liquefied breath with a fresh sample of liquefied condensed breath.
17. A system for monitoring, diagnosing, and treating a respiratory condition:
an apparatus for exposing a sensor to an individual's breath;
a processing receiver;
said sensor in a first real-time communication with said receiver;
22 said processing receiver processing said information . for determining various diagnoses and treatments; and
said processing receiver in a second communication with at least one treatment device to administer at least one therapeutic dose .
18. The system as recited in claim 17, wherein said apparatus is a general mask.
19. The system as recited in claim 17, wherein said respiratory condition is asthma.
20. The system as recited in claim 17, wherein said first communication is accomplished by a plurality of wires .
21. The system as recited in claim 17, wherein said first communication is accomplished by a wireless means
22. The system as recited in claim 17 , wherein said second communication is accomplished by a plurality of wires .
23. The system as recited in claim 17, wherein said second communication is accomplished by a wireless means ,
24. The system as recited in claim 17, wherein said sensor is designed to monitor pH.
23
25. The system as recited in claim 17 , wherein said treatment is a biocompatible agent capable of neutralizing an acidic condition.
26. The system as recited in claim 17, wherein said treatment is sodium bicarbonate.
27. The system as recited in claim 17 , further comprising a communication between said processing receiver and a nebulizer/atomizer/humidifier.
28. The system as recited in claim 17 , further comprising a third communication between said processing receiver and a continuous positive airway pressure device .
29. The system as recited in claim 17, wherein said apparatus includes a means to condense the individual' s breath to form a liquid pool in close proximity to said sensor.
30. The system as recited in claim 29, wherein said apparatus has a means to continuously circulate and replace said sample of liquefied breath with a fresh sample of liquefied condensed breath.
24
31. An apparatus for monitoring breath chemistry comprising:
a sensor;
a solid-state cooling means, said cooling means in physical engagement with said sensor;
a collection pool;
said cooling means reducing the temperature of said sensor below the dew point of a patient' s breath such that the patient' s breath condenses into a liquid that fills said collection pool; and
said sensor immersed in said liquefied breath in said collection pool .
32. An apparatus as recited in claim 31, further comprising an exit means to expel and replenish said collection pool with fresh liquefied patient' s breath condensate .
33. A method of monitoring a respiratory condition:
monitoring a chemical parameter of a patient' s breath with a sensor; and
25 communicating said chemical parameter in real-time under a sampling frequency from said sensor to a computing receiver.
34. A method of monitoring and diagnosing a respiratory condition:
monitoring a chemical parameter of a patient' s breath with a sensor;
communicating said chemical parameter in real-time under a sampling frequency from said sensor to a computing receiver; and
processing said chemical parameter information by a computing receiver to diagnose a patients' breath chemistry.
35. A method of monitoring, diagnosing and treating a respiratory condition:
monitoring a chemical parameter of a patient' s breath with a sensor;
communicating said chemical parameter in real-time under a sampling frequency from said sensor to a computing receiver;
26 processing said chemical parameter information by a computing receiver to diagnose a patients' breath chemistry.
performing a function on the occurrence of a threshold level; and
communicating with a treatment nebulizer/atomizer/ humidifier such that when the chemical parameter threshold level is reached, said computing receiver instructs said treatment nebulizer/atomizer/ humidifier to dispense one or more medicaments .
36. A method of monitoring a respiratory condition:
exposing a sensor to an environment that assesses a chemical parameter of the breath of a patient;
transferring in real-time said chemical parameter information to a processing receiver; and
converting the chemical parameter information communicated to the processing receiver to a digitized format.
27
37. A method of monitoring and diagnosing a respiratory condition:
exposing a sensor to an environment that assesses a chemical parameter of the breath of a patient;
transferring in real-time said chemical parameter information to a processing receiver; and
converting the chemical parameter information communicated to the processing receiver . to a digitized format to diagnose said chemical parameter information.
- 38. A method of monitoring, diagnosing and treating a respiratory condition:
exposing a sensor to an environment that assesses a chemical parameter of the breath of a patient;
transferring in real-time said chemical parameter information to a processing receiver;
converting the chemical parameter information communicated to the processing receiver to a digitized format to diagnose said chemical parameter information; and
28 processing said chemical parameter information for determining various treatments.
29
EP04750135.8A 2003-04-15 2004-04-15 Respiratory monitoring, diagnostic and therapeutic system Expired - Lifetime EP1613214B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/413,701 US7101341B2 (en) 2003-04-15 2003-04-15 Respiratory monitoring, diagnostic and therapeutic system
PCT/US2004/011548 WO2004100762A2 (en) 2003-04-15 2004-04-15 Respiratory monitoring, diagnostic and therapeutic system

Publications (3)

Publication Number Publication Date
EP1613214A2 true EP1613214A2 (en) 2006-01-11
EP1613214A4 EP1613214A4 (en) 2010-10-20
EP1613214B1 EP1613214B1 (en) 2016-10-05

Family

ID=33158596

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04750135.8A Expired - Lifetime EP1613214B1 (en) 2003-04-15 2004-04-15 Respiratory monitoring, diagnostic and therapeutic system

Country Status (6)

Country Link
US (2) US7101341B2 (en)
EP (1) EP1613214B1 (en)
JP (1) JP2007502688A (en)
AU (1) AU2004238209A1 (en)
CA (1) CA2520791C (en)
WO (1) WO2004100762A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112545896A (en) * 2020-12-29 2021-03-26 张青阳 Auxiliary medicine feeder for psychiatric department and using method thereof

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1505905A4 (en) * 2002-05-17 2006-01-25 Henry M Jackson Foundation BREATHABLE IMAGE DISPLAY
US7189204B2 (en) 2002-12-04 2007-03-13 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
US7662101B2 (en) 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
US7610094B2 (en) 2003-09-18 2009-10-27 Cardiac Pacemakers, Inc. Synergistic use of medical devices for detecting medical disorders
US8606356B2 (en) 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
EP2008581B1 (en) 2003-08-18 2011-08-17 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
EP1689287A1 (en) * 2003-12-01 2006-08-16 Sierra Medical Technology, Inc. A respiratory monitoring, diagnostic and therapeutic system
US7350519B2 (en) * 2003-12-29 2008-04-01 Timothy Alan Duncan Method and apparatus for delivering an additive with a CPAP machine
US7946291B2 (en) * 2004-04-20 2011-05-24 Novartis Ag Ventilation systems and methods employing aerosol generators
US7420797B2 (en) * 2004-07-16 2008-09-02 Cardiac Pacemakers, Inc. Plug for sealing a capacitor fill port
CA2578615A1 (en) * 2004-08-20 2007-01-04 University Of Virginia Patent Foundation Exhaled breath condensate collection and assay system and related method thereof
US20060042636A1 (en) * 2004-08-31 2006-03-02 Nalagatla Anil K Oral nasal cannula
WO2006043290A1 (en) * 2004-10-21 2006-04-27 Carlo Valesi A portable device for the condensation of the air exhaled by a mammal
AU2006220222A1 (en) * 2005-03-01 2006-09-08 Resmed Limited Recognition system for an apparatus that delivers breathable gas to a patient
DE102005020102B3 (en) * 2005-04-25 2006-11-30 Universität Potsdam Method and device for obtaining and analyzing respiratory condensates
US9757052B2 (en) 2005-05-10 2017-09-12 Oridion Medical (1987) Ltd. Fluid drying mechanism
KR100628464B1 (en) * 2005-07-06 2006-09-28 우리텍 주식회사 Atomizer for Ultrasonic Humidifier
WO2007019624A1 (en) 2005-08-15 2007-02-22 Resmed Ltd Cpap systems
US8545416B1 (en) * 2005-11-04 2013-10-01 Cleveland Medical Devices Inc. Integrated diagnostic and therapeutic system and method for improving treatment of subject with complex and central sleep apnea
US7942824B1 (en) * 2005-11-04 2011-05-17 Cleveland Medical Devices Inc. Integrated sleep diagnostic and therapeutic system and method
US8172766B1 (en) * 2005-11-04 2012-05-08 Cleveland Medical Devices Inc. Integrated sleep diagnosis and treatment device and method
WO2007059810A1 (en) * 2005-11-26 2007-05-31 Dräger Medical AG & Co. KG System for enabling operating modes on a multi-part medical appliance
US7913689B2 (en) 2005-12-21 2011-03-29 Resmed Limited Identification system and method for mask and ventilator components
DE102005062185B3 (en) * 2005-12-23 2007-07-12 Dräger Medical AG & Co. KG Ventilation device with active dehumidification
WO2008097307A2 (en) * 2006-01-25 2008-08-14 Kanzer Steve H Droplet collection devices and methods to detect and control airborne communicable diseases utilizing rfid
US7980245B2 (en) * 2006-05-12 2011-07-19 The General Electric Company Informative accessories
US20070283951A1 (en) * 2006-06-12 2007-12-13 Marc Alan Burk Mask-nebulizer assembly
US8720439B1 (en) * 2006-08-16 2014-05-13 Cleveland Medical Devices Inc. Humidification for continuous positive airway pressure systems
EP1905468B1 (en) 2006-09-29 2012-11-07 Zambon S.p.A. Aerosol apparatus, in particular for children
EP3088031B1 (en) * 2007-01-23 2020-03-18 Fisher & Paykel Healthcare Limited Humidification apparatus with rfid tag sensor
US8276587B2 (en) * 2008-02-15 2012-10-02 Tsi, Incorporated Automated qualitative mask fit tester
EP2106818B1 (en) 2008-03-31 2013-12-25 Nellcor Puritan Bennett Llc System for compensating for pressure drop in a breathing assistance system
US9615773B1 (en) * 2008-08-13 2017-04-11 Cleveland Medical Devices Inc. Method and device for sleep analysis and therapy
US8181648B2 (en) 2008-09-26 2012-05-22 Nellcor Puritan Bennett Llc Systems and methods for managing pressure in a breathing assistance system
US8302602B2 (en) 2008-09-30 2012-11-06 Nellcor Puritan Bennett Llc Breathing assistance system with multiple pressure sensors
AT507187B1 (en) 2008-10-23 2010-03-15 Helmut Dr Buchberger INHALER
EP2419720A4 (en) * 2009-04-15 2014-05-07 Nanomix Inc Breath condensate sampler and detector and breath/breath condensate sampler and detector
US8911380B1 (en) 2009-04-17 2014-12-16 Linshom, L.P. Respiration monitoring system and method
WO2010120891A2 (en) * 2009-04-17 2010-10-21 Linshom L.P. System and method for monitoring breathing
US8776790B2 (en) 2009-07-16 2014-07-15 Covidien Lp Wireless, gas flow-powered sensor system for a breathing assistance system
AU2010206053B2 (en) * 2009-07-31 2014-08-07 ResMed Pty Ltd Wire Heated Tube with Temperature Control System, Tube Type Detection, and Active Over Temperature Protection for Humidifier for Respiratory Apparatus
BR112012009703A8 (en) 2009-10-28 2017-10-10 Koninklijke Philips Electronics Nv PRESSURE SUPPORT SYSTEM AND METHOD FOR PROVIDING A GAS FLOW TO A PATIENT
AU2011245771B2 (en) * 2010-04-27 2015-05-07 Fisher & Paykel Healthcare Limited Apparatus for supplying gases to a patient
AU2015201563B2 (en) * 2010-04-27 2017-04-06 Fisher & Paykel Healthcare Limited Apparatus for Supplying Gases to a Patient
EP2591331A4 (en) 2010-07-06 2017-06-07 Deton Corp. System for airborne bacterial sample collection and analysis
DE102010054361B4 (en) 2010-12-13 2013-02-21 Nli Gmbh therapy device
PL2672847T3 (en) 2011-02-11 2015-10-30 Batmark Ltd Inhaler component
AT510837B1 (en) 2011-07-27 2012-07-15 Helmut Dr Buchberger INHALATORKOMPONENTE
WO2013034459A1 (en) 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Heating smokeable material
WO2013034460A1 (en) 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Heating smokable material
WO2013038264A2 (en) * 2011-09-16 2013-03-21 Northgate Technologies Inc. Carboxy therapy applicator
US20140364758A1 (en) * 2011-12-19 2014-12-11 Resmed Limited Respiratory treatment system including physiological sensors
US10111606B2 (en) * 2012-01-25 2018-10-30 The Regents Of The University Of California Integrated condenser for collecting droplets
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
AU2013257334B2 (en) * 2012-05-02 2017-10-26 Fisher & Paykel Healthcare Limited Respiratory humidifier communication systems and methods
US10748645B2 (en) 2012-08-16 2020-08-18 Ginger.io, Inc. Method for providing patient indications to an entity
US9617582B2 (en) 2012-09-04 2017-04-11 University Of Maryland College Park Human exhaled aerosol droplet biomarker system and method
CN204951885U (en) * 2012-09-14 2016-01-13 费雪派克医疗保健有限公司 A patient's interface shade for be used together with breathing auxiliary assembly
US10080857B2 (en) 2013-03-12 2018-09-25 Deton Corp. System for breath sample collection and analysis
WO2015061412A1 (en) * 2013-10-22 2015-04-30 The Scripps Research Institute Methods and compositions for promoting bronchioli dilatation
US9700695B2 (en) 2013-12-06 2017-07-11 James E Steiner, III Anti-aspiration mask system
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
CN104147674A (en) * 2014-09-03 2014-11-19 张春桂 Oxygen inhalation device with humidification function and atomization function
CN104458348B (en) * 2014-11-27 2017-02-01 浙江大学 Method and device for collecting PAEs in gas exhaled by human body
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
RU2018107453A (en) 2015-08-10 2019-09-12 Эссенликс Корп. DEVICES FOR ANALYSIS AND METHODS IN BIOLOGY / CHEMISTRY, PROVIDING SIMPLIFIED STAGES, SAMPLES OF SMALL VOLUME, INCREASED SPEED AND EASE OF APPLICATION
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
CA2998635C (en) 2015-09-14 2021-08-24 Essenlix Corporation Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same
SG10202104563UA (en) 2015-09-14 2021-06-29 Essenlix Corp Device and system for analyzing a sample, particularly blood, as well as methods of using the same
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
TWI577338B (en) * 2015-10-30 2017-04-11 元智大學 Based on the real-time image-based respiration rate measurement technology method
CN105833401A (en) * 2016-03-16 2016-08-10 张胜国 Portable intelligent air filtering positive-pressure assisted respiration and ultrasonic atomization device
US10894142B2 (en) 2016-03-24 2021-01-19 Trudell Medical International Respiratory care system with electronic indicator
US10502665B2 (en) 2016-04-18 2019-12-10 University Of Maryland, College Park Aerosol collection system and method
JP6861270B2 (en) * 2016-04-25 2021-04-21 アウルストーン・メディカル・リミテッドOwlstone Medical Limited Systems and devices for capturing exhaled breath samples
EP4309715A3 (en) 2016-04-27 2024-03-27 Nicoventures Trading Limited Electronic aerosol provision system and vaporizer therefor
CA3201693C (en) 2016-05-19 2025-09-09 Trudell Medical International Inc. Smart valved holding chamber
US10881818B2 (en) 2016-07-08 2021-01-05 Trudell Medical International Smart oscillating positive expiratory pressure device
WO2018094774A1 (en) * 2016-11-24 2018-05-31 华健 Electronic mask for use in coping with hazy climates
EP3551261B1 (en) 2016-12-09 2022-05-11 Trudell Medical International Smart nebulizer
CN207253550U (en) * 2016-12-16 2018-04-20 广东食品药品职业学院 Easy to the novel atomized administration device to patients undergoing nebulae inhalation
EP3558121B1 (en) 2016-12-21 2022-06-08 Essenlix Corporation Devices and methods for authenticating a sample and use of the same
CN111246945A (en) 2017-02-07 2020-06-05 Essenlix公司 Compressed open flow assay and use
CN111936837B (en) 2017-02-08 2024-06-07 上海宜晟生物科技有限公司 QMAX assay and use
CN119000153A (en) 2017-02-08 2024-11-22 上海宜晟生物科技有限公司 Sample analysis device and use thereof
US11927560B2 (en) 2017-02-08 2024-03-12 Essenlix Corporation Bio/chemical material extraction and assay
WO2018148609A2 (en) 2017-02-09 2018-08-16 Essenlix Corporation Colorimetric assays
CA3052986A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Molecular manipulation and assay with controlled temperature
JP7004732B2 (en) 2017-02-09 2022-01-21 エッセンリックス コーポレーション Assay method using different spacing heights
CN110998325B (en) 2017-02-09 2024-08-16 上海宜晟生物科技有限公司 Amplification assay
CN111194409B (en) 2017-02-15 2024-11-29 上海宜晟生物科技有限公司 Measurement using rapid temperature changes
CN120195095A (en) 2017-02-16 2025-06-24 上海宜晟生物科技有限公司 Measurement method and device using textured surface
CN112218720A (en) 2017-06-12 2021-01-12 Essenlix公司 Homogeneous assay
WO2019028123A1 (en) 2017-08-01 2019-02-07 Essenlix Corporation Sample collection, holding, and assaying
CN120668916A (en) 2017-08-01 2025-09-19 上海宜晟生物科技有限公司 Device and method for checking the effect of a drug on microorganisms
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
WO2019075244A1 (en) 2017-10-11 2019-04-18 Essenlix Corporation Containing a liquid sample
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
WO2019118652A1 (en) 2017-12-12 2019-06-20 Essenlix Corporation Sample manipulation and assay with rapid temperature change
WO2019118936A2 (en) 2017-12-14 2019-06-20 Essenlix Corporation Devices, systems, and methods for monitoring hair
EP3735287B1 (en) 2018-01-04 2025-03-05 Trudell Medical International Inc. Smart oscillating positive expiratory pressure device
WO2019140334A1 (en) 2018-01-11 2019-07-18 Essenlix Corporation Homogeneous assay (ii)
US11395890B2 (en) 2018-06-04 2022-07-26 Trudell Medical International Smart valved holding chamber
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging
CN111609649B (en) 2019-02-25 2022-01-18 Lg电子株式会社 Entrance refrigerator and refrigerator
CN111609651B (en) 2019-02-25 2022-06-28 Lg电子株式会社 Entrance refrigerator and refrigerator
EP3699521B1 (en) 2019-02-25 2023-09-06 LG Electronics Inc. Entrance refrigerator
CN111609647B (en) * 2019-02-25 2021-11-05 Lg电子株式会社 Entrance refrigerator and refrigerator
CN111609656A (en) 2019-02-25 2020-09-01 Lg电子株式会社 Entrance refrigerator and refrigerator
CN111609648A (en) 2019-02-25 2020-09-01 Lg电子株式会社 Entrance refrigerators and refrigerators
PL240433B1 (en) * 2019-05-26 2022-04-04 Wisniewski Jan Personal dust mask
PL240432B1 (en) * 2019-05-26 2022-04-04 Wisniewski Jan Personal dust mask
CN110251138A (en) * 2019-06-25 2019-09-20 王立霞 A kind of tcm internal medicine clinical diagnosis detection breathing equipment
CA3152072A1 (en) 2019-08-27 2021-03-04 Trudell Medical International Smart oscillating positive expiratory pressure device
US12442726B2 (en) * 2020-04-19 2025-10-14 John J. Daniels Mask-based testing system for detecting biomarkers in exhaled breath condensate, aerosols and gases
US11710576B2 (en) * 2021-05-24 2023-07-25 OrangeDot, Inc. Method and system for computer-aided escalation in a digital health platform
US12453827B2 (en) 2022-02-24 2025-10-28 Yale University Nebulizer gas scavenger system with medication recycling and consumption metering

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946726A (en) 1974-08-07 1976-03-30 Puriton-Bennett Corporation Pulmonary diagnostic instrument including breath transducer
US3991304A (en) 1975-05-19 1976-11-09 Hillsman Dean Respiratory biofeedback and performance evaluation system
US4098650A (en) * 1976-11-08 1978-07-04 Thermo-Lab Instruments, Inc. Method and analyzer for determining moisture in a mixture of gases containing oxygen
US4366821A (en) 1980-09-15 1983-01-04 Marie C. Kercheval Breath monitor device
US5174959A (en) 1986-12-22 1992-12-29 Abbott Laboratories Breath component monitoring device
US5522382A (en) 1987-06-26 1996-06-04 Rescare Limited Device and method for treating obstructed breathing having a delay/ramp feature
US5388571A (en) * 1987-07-17 1995-02-14 Roberts; Josephine A. Positive-pressure ventilator system with controlled access for nebulizer component servicing
US5081871A (en) 1989-02-02 1992-01-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Breath sampler
US5069220A (en) 1989-05-26 1991-12-03 Bear Medical Systems, Inc. Measurement of gas concentration in exhaled breath
US5265595A (en) 1989-06-19 1993-11-30 Hans Rudolph, Inc. Mask for breath analysis
US5042501A (en) 1990-05-01 1991-08-27 Battelle Memorial Institute Apparatus and method for analysis of expired breath
US5211181A (en) 1991-05-17 1993-05-18 Martek Corporation Apparatus and method for collecting human breath samples
SE9102812L (en) * 1991-09-27 1993-01-18 Lars Erik Gustafsson SETTING UPDATE CURRENT LUNG FUNCTION AND DEVICE TO INDICATE THESE LUNG FUNCTION
US5213109A (en) 1991-12-13 1993-05-25 Susi Roger E Airway adapter for monitoring constituents of a patient's breath
US5140993A (en) 1991-12-27 1992-08-25 Baylor College Of Medicine Device for collecting a breath sample
NZ250105A (en) 1992-11-09 1996-07-26 Monaghan Canadian Ltd Inhalator mask; one-way valve opens upon exhalation
SE470564B (en) 1993-01-19 1994-08-29 Hans Pettersson Method and apparatus for sensing the breathing of a human or animal
AU6251694A (en) 1993-02-24 1994-09-14 Martek Biosciences Corporation True alveolar breath collecting apparatus and method
WO1995002181A1 (en) 1993-07-06 1995-01-19 Kjell Alving A system to be used for the determination of no levels in exhaled air and diagnostic methods for disorders related to abnormal no levels
US5361772A (en) 1993-07-07 1994-11-08 Diagnostics & Devices, Inc. Breath collection devices
US5465728A (en) 1994-01-11 1995-11-14 Phillips; Michael Breath collection
US5826577A (en) 1996-01-30 1998-10-27 Bacharach, Inc. Breath gas analysis module
US5857460A (en) 1996-03-14 1999-01-12 Beth Israel Deaconess Medical Center, Inc. Gas-sensing mask
US6033368A (en) 1996-03-28 2000-03-07 Nitromed, Inc. Condensate colorimetric nitrogen oxide analyzer
DE69713581T3 (en) 1996-04-09 2007-09-13 Aperon Biosystems Inc., Palo Alto METHOD AND DEVICE FOR MEASURING INGREDIENTS IN HUMAN EXTRACTED AIR
US5795787A (en) 1996-04-09 1998-08-18 Silkoff; Philip Method and apparatus for the measurement of exhaled nitric oxide in humans
JP3061173B2 (en) * 1996-10-16 2000-07-10 アニマ株式会社 Portable respiratory analyzer
US5962335A (en) 1997-01-03 1999-10-05 Oridion Medical Ltd. Breath test for detection of drug metabolism
US6186958B1 (en) 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
GB9704676D0 (en) * 1997-03-06 1997-04-23 Aromascan Plc Condition indicator
US5996586A (en) 1997-03-26 1999-12-07 Phillips; Michael Breath test for detection of lung cancer
US6067983A (en) 1997-09-19 2000-05-30 Sensormedics Corporation Method and apparatus for controlled flow sampling from the airway
US6213955B1 (en) 1998-10-08 2001-04-10 Sleep Solutions, Inc. Apparatus and method for breath monitoring
AU776296B2 (en) * 1998-12-18 2004-09-02 University Of Virginia Patent Foundation Device and method for monitoring asthma
JP4415160B2 (en) 1999-01-12 2010-02-17 マイケル フィリップス, Breath test processing method for detecting various diseases
US6221026B1 (en) 1999-01-12 2001-04-24 Michael Phillips Breath test for the detection of various diseases
US6053874A (en) 1999-01-25 2000-04-25 Boditech Diagnostics Limited Breath collection and storage
US6479019B1 (en) * 1999-04-15 2002-11-12 Quantum Group, Inc. Sensor and sensor assembly for detecting a target gas in a breath sample
US6612306B1 (en) * 1999-10-13 2003-09-02 Healthetech, Inc. Respiratory nitric oxide meter
US6930125B2 (en) * 2000-01-14 2005-08-16 John F. Hunt Airway alkalinization as a therapy for airway diseases
WO2001093743A2 (en) * 2000-06-07 2001-12-13 Healthetech, Inc. Breath ketone analyzer
CA2885596A1 (en) * 2001-03-20 2002-09-26 Trudell Medical International Nebulizer apparatus with an adjustable fluid orifice
US6599253B1 (en) 2001-06-25 2003-07-29 Oak Crest Institute Of Science Non-invasive, miniature, breath monitoring apparatus
US20030023181A1 (en) * 2001-07-26 2003-01-30 Mault James R. Gas analyzer of the fluorescent-film type particularly useful for respiratory analysis
DE10137565B4 (en) * 2001-07-30 2004-07-15 Filt Lungen- Und Thoraxdiagnostik Gmbh Method for determining parameters of a breath condensate
US6582376B2 (en) 2001-09-13 2003-06-24 Pranalytica, Inc. Alveolar breath collection device and method
US6648833B2 (en) * 2001-10-15 2003-11-18 David R. Hampton Respiratory analysis with capnography
US7014612B2 (en) * 2001-11-13 2006-03-21 Photonic Biosystems, Inc. Method for diagnosis of helicobacter pylori infection
US7192782B2 (en) * 2002-01-11 2007-03-20 Ekips Technologies, Inc. Method and apparatus for determining marker gas concentration in exhaled breath using an internal calibrating gas
US7547285B2 (en) * 2003-02-14 2009-06-16 The Charlotte-Mecklenburg Hospital Authority Device and method for collection of exhaled alveolar breath condensate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112545896A (en) * 2020-12-29 2021-03-26 张青阳 Auxiliary medicine feeder for psychiatric department and using method thereof

Also Published As

Publication number Publication date
WO2004100762A3 (en) 2005-07-28
EP1613214A4 (en) 2010-10-20
EP1613214B1 (en) 2016-10-05
US7297120B2 (en) 2007-11-20
CA2520791C (en) 2014-01-28
WO2004100762A2 (en) 2004-11-25
CA2520791A1 (en) 2004-11-25
JP2007502688A (en) 2007-02-15
AU2004238209A1 (en) 2004-11-25
US20040210151A1 (en) 2004-10-21
US20040210153A1 (en) 2004-10-21
US7101341B2 (en) 2006-09-05

Similar Documents

Publication Publication Date Title
US7101341B2 (en) Respiratory monitoring, diagnostic and therapeutic system
US20070068811A1 (en) Respiratory monitoring, diagnostic and therapeutic system
US12350066B2 (en) Systems and methods for controlling position
US7736320B2 (en) Self-condensing pH sensor and catheter apparatus
US20070049842A1 (en) Sleep disorder diagnostic system and method
US20190320977A1 (en) Oral appliance monitoring
JP6496714B2 (en) Compression device and pressure sensor for treating functional abnormality of upper esophageal sphincter
EP4566543A2 (en) Acoustic sensor and ventilation monitoring system
US11213225B2 (en) Acoustic sensor and ventilation monitoring system
EP2200512A1 (en) Adherent device for respiratory monitoring and sleep disordered breathing
TW200405803A (en) Multi-function sensor device and methods for its use
JP7237833B2 (en) System and method, computer readable storage medium for facilitating detection of respiratory status
US20170049378A1 (en) Self-Condensing pH Sensor and/or Pepsin Sensor and Catheter Apparatus
US20240382707A1 (en) Bidirectional Spirometer T-Piece
US20240148299A1 (en) Ingestible anxiety monitoring and treatment system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050928

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/08 20060101AFI20060215BHEP

Ipc: G01N 31/00 20060101ALI20060215BHEP

Ipc: G01N 1/22 20060101ALI20060215BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100921

17Q First examination report despatched

Effective date: 20150302

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602004050065

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61B0005080000

Ipc: A61M0016000000

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 16/14 20060101ALI20160421BHEP

Ipc: A61B 5/145 20060101ALI20160421BHEP

Ipc: A61B 5/083 20060101ALI20160421BHEP

Ipc: A61M 16/06 20060101ALI20160421BHEP

Ipc: A61M 16/00 20060101AFI20160421BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160527

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 834078

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602004050065

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602004050065

Country of ref document: DE

Representative=s name: ARNOLD & SIEDSMA, DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ARNOLD AND SIEDSMA AG, CH

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20161005

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 834078

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170206

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602004050065

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170105

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

26N No opposition filed

Effective date: 20170706

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170415

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170415

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20040415

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161005

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230425

Year of fee payment: 20

Ref country code: DE

Payment date: 20230427

Year of fee payment: 20

Ref country code: CH

Payment date: 20230502

Year of fee payment: 20

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230712

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230427

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 602004050065

Country of ref document: DE

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20240414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20240414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20240414